Walder Wyss has acted as legal counsel to Swisscanto Invest by Zürcher Kantonalbank in connection with the series B financing round of Sulzer & Schmid Laboratories, an independent Swiss technology company of next-generation technology for the inspection of rotor blades. Walder Wyss acted with a team led by Alex Nikitine (partner, corporate/ m&a, pictured) and Dimitrios Berger […]
Advestra advises Kempen & Co. as the sole global coordinator and sole bookrunner on the placement of CHF 180 million unsecured, subordinated mandatory convertible bonds issued by Peach Property Group. On this transaction, Advestra team included
DomoSafety, a company in the digital health segment developing solutions in the field of patient safety, announced the successful closing of its Series B financing round. The investment was led by Hirslanden, a Swiss healthcare
Komgo – the trade finance blockchain joint venture – has successfully closed its third funding round by raising CHF 26 million. The round received a high level of interest from both new and returning investors. The investment brought
The insurtech startup Wefox – with its Zurich based parent company Wefox Holding (formerly FinanceApp) – has completed on 1 June a Series C financing round of 650 million USD. The legal team Walder Wyss advised the company in
ViboTec, the provider of an AI-based virtual advertising system for live sports, closes its seven-digit Seed Financing Round with Fraunhofer Tech Transfer Fund FTFF und the industry investors Dr. Nico Brunner, Hans-Milovan Halhuber and Bernd
Numab Therapeutics, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, successfully closes CHF 100 million (approximately USD 110 million) in Series C financing Round. The financing was co-led by new investors
MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany.
The Kellerhals Carrard Startup Desk acted as legal counsel to Qnami, a Quantum Tech startup, in closing its Series A Financing Round raising a total of CHF 4 million. Led by the Venture Capital Funds Runa
Vischer acted as legal counsel for Haya Therapeutics, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), on the closing of its CHF 18 million seed round. The financing was led
